IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FRANCESCHINI, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.694
EU - Europa 7.818
AS - Asia 2.685
AF - Africa 24
SA - Sud America 22
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 21.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.653
IT - Italia 3.667
CN - Cina 1.585
UA - Ucraina 1.441
DE - Germania 841
HK - Hong Kong 600
FI - Finlandia 413
IE - Irlanda 360
SG - Singapore 339
GB - Regno Unito 328
FR - Francia 266
PL - Polonia 135
SE - Svezia 100
RU - Federazione Russa 79
IN - India 65
BE - Belgio 38
CA - Canada 38
TR - Turchia 34
ES - Italia 23
NL - Olanda 18
RO - Romania 18
CZ - Repubblica Ceca 16
AU - Australia 14
EU - Europa 14
VN - Vietnam 14
CH - Svizzera 13
BR - Brasile 12
MK - Macedonia 11
EG - Egitto 10
GR - Grecia 9
IR - Iran 9
JP - Giappone 8
LU - Lussemburgo 8
SA - Arabia Saudita 6
AT - Austria 5
CI - Costa d'Avorio 5
UG - Uganda 5
BG - Bulgaria 4
CL - Cile 4
IL - Israele 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
JO - Giordania 3
LI - Liechtenstein 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
SI - Slovenia 3
AM - Armenia 2
DK - Danimarca 2
ID - Indonesia 2
IQ - Iraq 2
LT - Lituania 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
KZ - Kazakistan 1
MS - Montserrat 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
VE - Venezuela 1
Totale 21.275
Salva come PNG Salva come JPEG
Città #
Fairfield 1.572
Woodbridge 1.143
Jacksonville 1.085
Ashburn 795
Houston 794
Cambridge 625
Hong Kong 598
Seattle 588
Ann Arbor 587
Wilmington 563
Princeton 549
Chandler 477
Nanjing 350
Dublin 292
Beijing 286
New York 278
Helsinki 258
Milan 243
Singapore 195
Brescia 165
Rome 150
Warsaw 129
Nanchang 121
San Diego 110
Des Moines 105
Hebei 105
Shenyang 99
Florence 94
Shanghai 84
Changsha 78
Tianjin 73
Jinan 67
Jiaxing 63
Verona 57
London 52
Trieste 52
Hangzhou 47
Bergamo 44
Dearborn 42
San Francisco 41
Turin 41
Lancaster 38
Brussels 34
Udine 34
Kunming 32
Ningbo 32
Genoa 31
Padova 30
Bologna 26
Toronto 25
Genova 24
Lappeenranta 24
Pisa 23
Taizhou 23
Haikou 22
Lanzhou 22
Zhengzhou 22
Kocaeli 21
Los Angeles 21
Syracuse 21
Boardman 20
Menlo Park 20
Munich 19
Torino 19
Nürnberg 18
Reggio Nell'emilia 18
Mumbai 17
Redwood City 17
Guangzhou 15
Norwalk 15
Orange 15
Rozzano 15
Washington 15
Brno 14
Dong Ket 14
Monmouth Junction 14
Pune 14
Trento 14
Modena 13
Palermo 13
San Mateo 13
Kilburn 12
Bari 11
Dallas 11
Ferrara 11
Paris 11
Pordenone 11
Rho 11
Catania 10
Cosenza 10
Desio 10
Falkenstein 10
Melbourne 10
Mountain View 10
Naples 10
Napoli 10
Pozzuolo Del Friuli 10
Sassari 10
Perugia 9
Prescot 9
Totale 14.130
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.007
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.449
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 180
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 156
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 152
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 148
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 137
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 135
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 127
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 127
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 124
Antiphospholipid antibodies mediate autoimmunity against dying cells. 123
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 119
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 119
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 119
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 118
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 117
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 117
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 115
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 114
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 114
The clinico-serological spectrum of overlap myositis 114
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 113
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 112
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 112
Autoimmune polyendocrine Syndromes 110
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 110
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 109
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 107
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 106
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 106
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 104
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 104
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 103
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 103
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 103
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 103
Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: The positive experience of a national multicentre study 102
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 101
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 101
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 101
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 101
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 99
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 99
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 98
Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide 97
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 97
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 97
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 95
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 95
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 95
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 95
Incidence of antiperinuclear factor in patients with psoriatic arthritis. 94
Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. 94
Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference 92
Antiperinuclear factor in psoriatic arthropathy 91
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 91
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 90
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 89
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 89
Pathogenetic associations of maternal anti-Ro/SSA antibodies. 89
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 89
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 88
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 88
Anti-Ro/SSA and La/SSB antibodies 88
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 87
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 86
Myositis autoantibodies and clinical phenotypes 85
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 85
Determination of antibodies to extractable nuclear antigens by commercial kits: a multicenter study 85
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 84
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 84
Switching from Intravenous to Subcutaneous Formulation of Abatacept: A Single-center Italian Experience on Efficacy and Safety 84
The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus 84
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 84
Update on Antiphospholipid Syndrome: Ten Topics in 2017 84
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 84
Serologic profile and mortality rates of scleroderma renal crisis in Italy 83
In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings. 83
Cardiological features in idiopathic inflammatory myopathies. 82
Incidence of antiperinuclear factor in sera of patients with psoriatic arthritis 80
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 80
Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al 80
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 80
Echocardiographic Evaluation of Asymptomatic Patients Affected by Rheumatoid Arthritis 79
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 79
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 79
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 78
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 78
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 78
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 78
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 78
Retention of a bile acid analogue in the enterohepatic circulation (EHC) in primary biliary cirrhosis (PBC): comparison with normal controls and effect of bile acid treatment. 77
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 77
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience. 77
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 76
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 75
Transient neonatal bradycardia without heart block associated with anti-Ro antibodies 75
Diastolic dysfunction in rheumatoid arthritis: a usual travel-mate? 75
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 74
Totale 13.098
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.647
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.647
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.026 782 162 187 528 285 510 414 538 384 748 166 322
2020/20214.009 94 438 162 444 242 467 156 446 466 472 395 227
2021/20223.010 185 401 140 176 164 200 201 234 193 296 272 548
2022/20232.266 341 38 51 99 194 564 47 229 384 56 139 124
2023/20242.853 150 84 228 246 134 458 134 138 667 94 107 413
2024/202581 81 0 0 0 0 0 0 0 0 0 0 0
Totale 21.741